New user? Click here to register.Have you forgotten your password?
Repository logoRepository logo
Who We Are✱Collections✱News and Events✱Contacts
  1. Home
  2. PUBBLICAZIONE/PUBLICATION
  3. Journal Article
  4. Trial characteristics associated with under-enrolment of females in randomized controlled trials of heart failure with reduced ejection fraction: a systematic review
Details

Trial characteristics associated with under-enrolment of females in randomized controlled trials of heart failure with reduced ejection fraction: a systematic review

Publication type
journal article
Publication date
2021
Author(s)
Whitelaw, Sera
Sullivan, Kristen
Eliya, Yousif
Alruwayeh, Mohammad
Thabane, Lehana
more
Language
English
Keywords

Female

Humans

Male

Adult

Asia

Europe

Enrolment

Heart Failure

Middle Aged

North America

Randomized Controlled...

Sex

Gender

View point(s)
Reviews
Geographical area

Canada

Europe

USA

Abstract
AIMS: To evaluate temporal trends in the enrolment of females in randomized controlled trials (RCTs) of heart failure with reduced ejection fraction (HFrEF) published in high-impact journals, and assess RCT characteristics associated with under-enrolment. METHODS AND RESULTS: We searched MEDLINE, EMBASE and CINAHL for studies published from January 2000 to May 2019 in journals with impact factor ≥10. We included RCTs that recruited adults with HFrEF. We used a 20% threshold below the sex distribution of HFrEF to define under-enrolment. We used multivariable logistic regression to assess trial characteristics independently associated with under-enrolment. We included 317 RCTs. Among the 183 097 participants, mean (standard deviation) age was 63.0 (7.0) years and 25.5% were female. Females were under-enrolled in 71.6% [95% confidence interval (CI) 66.6-76.6%] of the RCTs; enrolment did not increase significantly between 2000-2019. Sex-related eligibility criteria [odds ratio (OR) 2.05, 95% CI 1.01-4.16; P = 0.046]; recruitment in ambulatory settings (OR 2.56, 95% CI 1.37-4.81; P = 0.003); trial coordination in North America (OR 4.44, 95% CI 1.09-18.07; P = 0.037), Europe (OR 6.79, 95% CI 1.63-27.39; P = 0.018) and Asia (OR 9.33, 95% CI 1.40-12.40; P = 0.033); drug (OR 1.76, 95% CI 1.96-7.36; P < 0.001) and device/surgical interventions (OR 1.69, 95% CI 1.16-9.43; P = 0.002); and men in first and last authorship position (OR 1.32, 95% CI 1.12-3.54; P = 0.047) were associated with under-enrolment of females. CONCLUSIONS: Females were under-enrolled relative to disease distribution in a majority of high-impact HFrEF RCTs, with no change in temporal trends between 2000 and 2019. Trial characteristics and gender of trial leaders were associated with under-enrolment.
Journal
European Journal of Heart Failure
ISSN
1879-0844
DOI
10.1002/ejhf.2034
Volume
23
Issue
1
Pagination
15-24
https://libkey.io/libraries/2561/articles/419463120/full-text-file?utm_source=api_2667&allow_speedbump=true
Repository logo
Sistema Bibliotecariodi Ateneo SBA
gendermore@unimore.it
www.sba.unimore.it
Privacy policy
End User Agreement
Send Feedback

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Accessibility settings
Repository logo COAR Notify